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Introduction
Human transmissible spongiform encephalopathy (TSE) in-
cludes classic Creutzfeldt-Jakob disease (CJD) and its variant 
form, Gerstmann-Sträussler-Scheinker syndrome (GSS), fatal 
familial insomnia, and kuru.
1 Most cases of human TSE are 
sporadic, but it can also occur in genetic and acquired forms. 
GSS is a rare genetic form of TSE that was originally de-
scribed in a large Austrian family, but it has never been re-
ported in Korea.
2,3 Typically, it is determined genetically by a 
range of mutations within the open reading frame of the pri-
on protein gene (PRNP) on chromosome 20.
4 
The clinical spectrum of this syndrome is more diverse than 
that of sporadic CJD, including slowly progressive cerebellar 
ataxia and late cognitive decline. The disease progresses 
more slowly than dose sporadic CJD, and the overall disease 
duration may last several months to several years (median 5 
years).
2,3 The present report is of the first case of GSS (con-
firmed by PRNP analysis) in Korea. Distinctive MRI findings 
are also presented and discussed.
Case Report 
A 46-year-old woman was admitted due to a slowly progres-
sive gait and speech disturbance that had first appeared 3 years 
earlier. Initially, she experienced gait difficulty due to ataxia, 
which slowly progressed. Six months later, she noticed dysar-
thria. On examination at the previous hospital, her speech was 
explosive and gait was ataxic. She revealed an abnormal tan-
dem gait, but the Romberg test was negative. The finger-to-
nose test indicated slight dysmetria, but there was no dysdi-
adochokinesia. The deep tendon reflex response was normal 
and there were no pathological reflex responses. Motor and 
sensory function tests showed no abnormalities. Cognitive 
decline developed 1 year prior to admission to our hospital. 
Her neurological deficits had become increasingly aggravat-
ed and she had been bedridden for the previous 2 months. In 
the family history, two sisters out of seven siblings developed 
similar symptoms in their fourth and fifth decades, respec-
tively, and both expired approximately 5 years after the onset 
of symptoms. Gene analysis for spinocerebellar ataxia (SCA1, 
2, 3, 6, 7) was negative.
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On examination, she appeared chronically ill. Her arousal 
level was good, but she lacked awareness. She could not co-
operate during the neurological examination or respond to 
even simple commands due to severe dementia. She could not 
produce meaningful words, making only incomprehensible 
sounds due to language dysfunction and severe dysarthria. The 
only meaningful response was crying after a painful stimu-
lus. Weakness in both of her lower extremities (MRC Grade 
III) along with signs of frontal lobe disease including the 
grasp, snout, palmomental, and glabellar reflexes were also 
evident. She fidgeted with her fingers and persistently exhib-
ited perioral dyskinesia whilst mimicking chewing. She 
could not walk without assistance for 1 year prior to admis-
sion due to progressive ataxia. The deep tendon reflex res-
ponse was decreased, but plantar responses were extensor 
bilaterally. Myoclonic movements were not observed. 
The results of blood studies - including chemistry, syphilis 
serology, human immunodeficiency virus serology, and a thy-
roid function test - were inconclusive. In brain MRI, high sig-
nal intensities over the entire hemispheric cortex were evident 
in fluid attenuated inversion recovery (FLAIR) imaging; this 
was significant in diffusion-weighted imaging (DWI). Follow-
Fig. 1. Serial MRI images of the patient. Widespread asymmetric cortical lesions with high signal intensities in FLAIR imaging and DWI 
were evident (A), and were more extended 5 months later (B). FLAIR: fluid attenuated inversion recovery, DWI: diffusion-weighted imaging.
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up images obtained 4 months later revealed the progression 
of the cerebral cortex signal changes from asymmetric to sym-
metric (Fig. 1). There was no definite change in the basal gan-
glia or cerebellum. Phosphorus-magnetic resonance spectros-
copy (MRS) was performed using a 1.5-tesla system. FLAIR 
axial images and volumes of interest were obtained in the pa-
rietal cortex and basal ganglia. There were no significant ab-
normal MRS findings. 
18F-FDG PET showed marked hypome-
tabolism in the bilateral frontal and parietotemporal areas, 
with lesser amounts in the primary visual, motor and sensory 
cortices, basal ganglia, and cerebellum (Fig. 2). 14-3-3- protein 
was present in the CSF (Fig. 3). EEG performed during admis-
sion showed non-specific generalized slow waves, mainly in 
the theta range. PRNP analysis revealed a proline-to-leucine 
(P102L) mutation in codon 102 (Fig. 4). Additionally, a gene 
study revealed that two of her three children carried the same 
mutation. Her condition worsened, and she is currently being 
cared for at a nursing home. 
Discussion
The original case of GSS was described in a large Austrian 
family with autosomal dominant inheritance. The typical cli-
nical feature is slowly progressive cerebellar ataxia, beginn-
ing in the fifth or sixth decade (but onset may occur as early 
as 25 years), admixed with cognitive decline that appears at 
some time during the course of the illness.
2,3 Unlike sporadic 
CJD, GSS involves a long period of illness: a mean of 5-6 
years, ranging from 3 months to 13 years. Although the pres-
ent case was a typical presentation with most of these classi-
cal features, several physicians failed to diagnose her case for 
2 years, which is due to the rarity of the condition. Cerebellar 
symptoms were prominent even at an early stage, but there are 
several other diseases that present with ataxia. Several re-
ports have indicated that MRI scans are normal during the 
early stage of GSS, with normal cerebellar findings being 
common in GSS patients.
5 Therefore, this is useful for differ-
entiating it from the cerebellar ataxia that usually appear as 
cerebellar atrophy and hypoperfusion in imaging studies. Al-
though the present case exhibited obvious cerebellar symp-
toms, the cerebellum was normal in MRI and PET studies. 
Arata et al.
5 suggested that the findings of dysesthesia and the 
absence of deep tendon reflexes at an early stage are impor-
tant for differentiating between GSS and cerebellar ataxia.
Since the initial description of the P102L mutation which 
remains the most common, as confirmed in the descendants of 
the original Austrian family, various PRNP mutations have 
been described for GSS phenotypes.
4 The onset occurred in 
the fourth decade for the younger sister of our case, which is 
less typical, but it is known that the clinical features vary for 
the P102L mutation.
6 The death of her sisters after a neurolog-
ical degenerative disorder with clinical similarities and the 
positive results of PRNP analyses for her children indicates 
that she had familial autosomal dominant GSS. 
In general, the definitive diagnosis of a prion disease re-
quires a brain biopsy or an autopsy with immunohistologic 
and genetic studies. Several ancillary tests are useful for this. 
EEG usually demonstrates generalized triphasic periodic 
sharp waves (PSW) in sporadic CJD. CSF testing for the 14-
Fig. 2. 
18F-FDG PET shows widespread asymmetric reduction of glucose metabolism in the cerebral cortical areas.
1 2 3 4 5
Fig. 3. Western blot analysis of CSF revealed the presence of 14-
3-3 protein. Lane 1: CSF CJD Positive, Lane 2: CSF (Patient), 
Lane 3: CSF (Positive), Lane 4: CSF (Negative), Lane 5: CSF (Ne-
gative), CJD: Creutzfeldt-Jakob disease. Park MJ et al.
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3-3 protein can also be helpful.
7,8 However, these methods 
are not sensitive for genetic TSE. The present case tested pos-
itive for CSF 14-3-3 protein but had non-specific EEG results. 
These findings are in agreement with previous reports; the 
EUROCJD collaborative surveillance project found that near-
ly 50% of GSS cases were positive for the 14-3-3 protein in 
CSF, while EEG tests showed typical pseudoperiodic activity 
in only 2 of 26 patients.
9 Unlike the PSW or CSF 14-3-3 pro-
tein, MRI is not used in the World Health Organization CJD 
diagnostic criteria; however, its importance is increasing. 
MRI can be helpful for diagnosing specific types of human 
prion disease. For example, the pulvinar sign appears to be 
relatively specific to variant CJD. It was recently reported 
that DWI can assist with the early diagnosis and understand-
ing of the relationship between lesions and neuropatholo-
gy.
10,11 One study showed that DWI is more sensitive for an 
early clinical diagnosis of CJD than are tests involving PSW, 
CSF 14-3-3 protein, and CSF neuron-specific enolase.
10 Previ-
ous studies found that the usual neuro-imaging findings for 
GSS may be normal or show non-specific atrophy affecting 
the cerebral hemispheres and/or cerebellum and, rarely, de-
creased T2-weighted signal changes in the basal ganglia.
12 
Only a few studies have found abnormally high signal inten-
sities in DWI of the cerebral cortex in GSS.
13,14 The present 
case showed a high signal intensity in FLAIR imaging and 
DWI signals that were similar to those of sporadic CJD. Fur-
thermore, the abnormally high DWI signal intensity was 
confined to the right hemisphere at 5 months prior to admis-
sion; it subsequently extended to both hemispheres, corres-
ponding to disease progression. This case confirmed that 
DWI is more sensitive than conventional T2-weighted and 
FLAIR imaging in detecting GSS lesions, especially in the 
early stages. In patients with CJD, a high DWI signals corre-
sponds to spongiform changes and astrocytic gliosis.
11 Since 
the GSS syndrome is also included in the TSE category, a si-
milar signal abnormality may be described by the same mech-
anism. Proton MRS has recently been reported to be useful 
in detecting subtle ongoing neural changes in patients with 
GSS syndrome.
15 However, no abnormal finding in MRS was 
found in the present case. It is possible that our patient was in 
an early or intermediate stage in which neuronal damage was 
not severe. 
This case is presented to alert clinicians that although it is a 
very rare human prion disease, GSS should be considered in 
the differential diagnosis when hereditary cerebellar ataxia and 
progressive cognitive decline develops. Unlike CJD, GSS is 
characterized by long periods of illness, and dementia develops 
late in the course of the illness. The utilization of diffusion-
weighted MRI is suggested for the early diagnosis of GSS.
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